Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Nov 4 2019

Full Issue

Google Jumps Into Fitness Tracking Business With $2.1B Fitbit Acquisition

The entry into the crowded field marks the latest effort by tech giants to secure a piece of the lucrative wearables marketplace.

The Associated Press: One Big Step: Google Buys Fitbit For $2.1 Billion

Google, the company that helped make it fun to just sit around surfing the web, is jumping into the fitness-tracker business with both feet, buying Fitbit for about $2.1 billion. The deal could put Google in direct competition with Apple and Samsung in the highly competitive market for smartwatches and other wearable electronics. But it also raises questions about privacy and Google's dominance in the tech industry. (O'Brien, 11/1)

The New York Times: Google To Buy Fitbit For $2.1 Billion

The acquisition is likely to face regulatory scrutiny from agencies already investigating Google for antitrust concerns, because Fitbit collects sensitive information from users through the device. In an effort to head off that potentially thorny point, Google said it would not use health data gleaned from Fitbit devices in its core advertising business. “You will always be in control of your data, and we will remain transparent about the data we collect and why,” Fitbit’s chief executive, James Park, said in an email to his company’s customers on Friday morning. “We never sell your personal information, and Fitbit health and wellness data will not be used for Google ads.” (Wakabayashi and Satariano, 11/1)

Stat: Google To Acquire Fitbit For $2.1 Billion In Major Health Tech Deal 

In recent months, Fitbit has been aggressively building out a health business, a division within the company known as Fitbit Health Solutions. Over a year ago, the company launched Fitbit Care, an offering aimed at employers and health plans that pay Fitbit to monitor and coach people with chronic conditions including obesity, diabetes, and hypertension. Those enterprise customers can choose various plans at escalating prices, paying more to have Fitbit’s network of human coaches involved in helping people manage their conditions. (Thielking and Robbins, 11/1)

Stat: 5 Burning Questions About Google’s Fitbit Acquisition — And Its Implications For Health And Privacy

Google parent company Alphabet’s move to buy Fitbit, announced Friday, comes with big questions for the growing push in health and medicine to make use of data collected from smartwatches and fitness trackers. ...This isn’t Google’s first foray into wearables technology. The company’s Verily unit, which is focused on health care, had previously worked with something known as the “study watch,” which was used in clinical trials. In January, that device received clearance from the Food and Drug Administration to be used to take electrocardiograms. (Robbins and Herper, 11/1)

In other health industry news —

Reuters: Healthineers Forecasts Growth On Demand For Hospital Equipment

Siemens Healthineers said it expected strong growth to continue next year, as the German maker of medical imaging machines and diagnostic equipment reported better than expected fourth-quarter sales on Monday. Healthineers' shares jumped 8% in early morning trade to its highest level on record. (11/4)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF